Search Results - "Stockschlaeder, M"

Refine Results
  1. 1

    Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery by Klein, H M, Ghodsizad, A, Marktanner, R, Poll, L, Voelkel, T, Mohammad Hasani, M R, Piechaczek, C, Feifel, N, Stockschlaeder, M, Burchardt, E R, Kar, B J, Gregoric, I, Gams, E

    Published in The Heart surgery forum (01-01-2007)
    “…Cell transplantation for myocardial regeneration has been shown to have beneficial effects on cardiac function after myocardial infarction. Most clinical…”
    Get more information
    Journal Article
  2. 2

    Retrospective comparison of maternal vs. HPA-matched donor platelets for treatment of fetal alloimmune thrombocytopenia by Giers, G., Wenzel, F., Fischer, J., Stockschläder, M., Riethmacher, R., Lorenz, H., Tutschek, B.

    Published in Vox sanguinis (01-04-2010)
    “…Background and Objectives  In fetal alloimmune thrombocytopenia (FAIT), transplacental maternal antibodies cause destruction of fetal platelets. FAIT is…”
    Get full text
    Journal Article
  3. 3

    Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation by KOEHNE, G, ZELLER, W, STOCKSCHLAEDER, M, ZANDER, A. R

    Published in Bone marrow transplantation (Basingstoke) (01-01-1997)
    “…The expression of CD45RA+ and CD45RO+ isoforms on T cells and the recovery of B lymphocytes and NK cells after autologous peripheral blood stem cell…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Adult Langerhans cell histiocytosis by Stockschlaeder, Marcus, Sucker, Christoph

    Published in European journal of haematology (01-05-2006)
    “…:  Langerhans cell histiocytosis (LCH) is a proliferative histiocytic disorder of unknown cause originating from dendritic cells. The clinical presentation of…”
    Get full text
    Journal Article
  7. 7

    Repeated infusions of VWF/FVIII concentrate: impact of VWF:FVIII ratio on FVIII trough and peak levels in a rabbit model by RAQUET, E., STOCKSCHLÄDER, M., DICKNEITE, G.

    “…The ratio of von Willebrand factor (VWF) to FVIII differs among available VWF/FVIII concentrates. Repeated infusions of concentrates with a low VWF:FVIII ratio…”
    Get full text
    Journal Article
  8. 8

    A pilot study of low-dose cyclosporin for graft-versus-host prophylaxis in marrow transplantation by Stockschlaeder, M, Storb, R, Pepe, M, Longton, G, McDonald, G, Anasetti, C, Appelbaum, F, Doney, K, Martin, P, Sullivan, K

    Published in British journal of haematology (01-01-1992)
    “…Nineteen patients with leukaemia, preleukaemia, and aplastic anaemia were treated by marrow transplantation from HLA-identical siblings. All were given…”
    Get more information
    Journal Article
  9. 9

    Amyloidosis and Bleeding: Pathophysiology, Diagnosis, and Therapy by Sucker, Christoph, Hetzel, Gerd Ruediger, Grabensee, Bernd, Stockschlaeder, Marcus, Scharf, Ruediger E.

    Published in American journal of kidney diseases (01-06-2006)
    “…Amyloid diseases can be associated with potentially life-threatening hemorrhage. Pathogenetic factors contributing to the abnormal bleeding tendency in this…”
    Get full text
    Journal Article
  10. 10

    Long-Term Transplantation of Canine Keratinocytes Made Resistant to G418 Through Retrovirus-Mediated Gene Transfer by Mary E. D. Flowers, Marcus A. R. Stockschlaeder, Schuening, Friedrich G., Niederwieser, Dietger, Hackman, Robert, Miller, A. Dusty, Storb, Rainer

    “…We studied cultured canine keratinocytes to determine whether they could serve as targets for retrovirus-mediated gene transfer and whether infected cells…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia by FIELDER, W, GRAEVEN, U, ERGÜN, S, VERAGO, S, KILIC, N, STOCKSCHLÄDER, M, HOSSFELD, D. K

    Published in Leukemia (01-08-1997)
    “…FLT4 represents a recently cloned member of class III receptor tyrosine kinases which include receptors for the angiogenic growth factor VEGF, namely FLT1 and…”
    Get full text
    Journal Article
  13. 13

    Intraoperative isolation and processing of BM-derived stem cells by Ghodsizad, A., Klein, H.-M., Borowski, A., Stoldt, V., Feifel, N., Voelkel, T., Piechaczek, C.H., Burchardt, E.R., Stockschläder, M., Gams, E.

    Published in Cytotherapy (Oxford, England) (01-10-2004)
    “…To improve tissue regeneration of ischemic myocardium, autologous bone marrow-derived stem cells have been injected intramyocardially in five patients…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Autologous transplantation of CD133 super(+) BM-derived stem cells as a therapeutic option for dilatative cardiomyopathy by Ghoclsizad, A, Ruhparwar, A, Marktanner, R, Borowski, A, Hasani, M M, Poll, L, Vshivkov, I, Stoldt, V, Voelkel, T, Piechaczek, C, Burchardt, E, Stockschlaeder, M, Sucker, C, Gams, E, Klein, H

    Published in Cytotherapy (Oxford, England) (01-05-2006)
    “…We report the case of a 58-year-old man with end-stage non-ischemic cardiomyopathy. Baseline transthoracic echocardiography (TTE) and cardiac magnetic…”
    Get full text
    Journal Article
  16. 16

    Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow by Zander, A R, Zabelina, T, Kröger, N, Renges, H, Krüger, W, Löliger, C, Dürken, M, Stockschläder, M, de Wit, M, Wacker-Backhaus, G, Bielack, S, Jaburg, N, Rüssmann, B, Erttmann, R, Kabisch, H

    Published in Bone marrow transplantation (Basingstoke) (01-05-1999)
    “…A five-agent GVHD prophylaxis programme consisting of cyclosporin A, methotrexate, anti-thymocyte-globulin, pentaglobin and metronidazol was given to 48…”
    Get full text
    Journal Article
  17. 17

    Amphotropic Murine Leukemia Viruses Induce Spongiform Encephalomyelopathy by Münk, Carsten, Löhler, Jürgen, Prassolov, Vladimir, Just, Ursula, Stockschläder, Marcus, Stocking, Carol

    “…Recombinants of amphotropic murine leukemia virus (A-MuLV) have found widespread use in retroviral vector systems due to their ability to efficiently and…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Serum interleukin-6 levels during bone marrow transplantation: impact on transplant-related toxicity and engraftment by Steffen, M, Dürken, M, Pichlmeier, U, von dem Busche, C, Stockschläder, M, Krüger, W, Budde-Steffen, C, Zander, A

    Published in Bone marrow transplantation (Basingstoke) (01-08-1996)
    “…The biological properties of IL-6 include the induction of acute phase proteins, stimulation of hematopoietic stem cell growth and thrombopoiesis. Serum levels…”
    Get more information
    Journal Article
  20. 20

    Faster engraftment of peripheral blood progenitor cells compared to bone marrow from unrelated donors by Ringdén, O, Hägglund, H, Runde, V, Basu, O, Kroschinsky, F, Stockschläder, M, Potter, M N

    Published in Bone marrow transplantation (Basingstoke) (01-06-1998)
    “…Twenty-six patients received peripheral blood progenitor cells (PBPC) from unrelated donors at five European Centres. Twenty-five donors were HLA-A, -B and -DR…”
    Get full text
    Journal Article Conference Proceeding